Please login to the form below
Otsuka
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.
Takeda grows in Turkey with Neutec subsidiary acquisition
Other companies investing in Turkey of late include Amgen - which bought local producer Mustafa Nevzat in 2012 for $700m - while Sanofi, Otsuka and Recordati are among companies building manufacturing capacity in
J&J gets quicker review for schizophrenia depot in US
in the summer, as well as two novel antipsychotics - Otsuka/Lundbeck's brexpiprazole and cariprazine from Actavis and Gedeon Richter.
Deal Watch table for December 2014
Company acquisition. 9, 500. Avanir Pharmaceuticals / Otsuka Pharmaceutical. Portfolio of CNS products, inc Nuedexta marketed for pseudobulbar affect. ... Research collaboration, options to license. 125. ††Ariad Pharmaceuticals / Otsuka Pharmaceutical
Pharma deals during December 2014
Also on the acquisition trail were Otsuka and Roche buying into CNS products for diseases with high unmet need and bispecific antibody technology, respectively.
Patent cliff losses set to cost pharma $65bn by 2019
Lilly, AZ and Otsuka to be hit hard, says GlobalData. Pharma firms should brace themselves for an estimated $65bn drop in sales by 2019 due to patent expiries on several leading ... Research and consulting company GlobalData says a significant proportion
[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
PMHub
ahair@onyxhealth.com
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- Why big pharma needs to be braver
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
